VEDOLIZUMAB
Manner of administration:Injection
Restriction
Indication: Moderate to severe chronic pouchitis
Treatment phase: Initial 1 treatment (new patient)
Restriction
Indication: Moderate to severe chronic pouchitis
Treatment phase: Initial 2 treatment (Recommencement of treatment after a break in biological medicine)
Restriction
Indication: Moderate to severe chronic pouchitis
Treatment phase: Balance of Supply - Initial 1 treatment (new patient) and Initial 2 treatment (recommencement
of treatment after a break in biological medicine)
Restriction
Indication: Moderate to severe chronic pouchitis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 2 | DPMQ: $2,851.31 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Entyvio | |||||